SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/0C6259231C9396B3821624E2F36D090E53F91524E840521C076AA4CCF48FF57731E91135B2BF2CB447A0CD9890722B56>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/0C6259231C9396B3821624E2F36D090E53F91524E840521C076AA4CCF48FF57731E91135B2BF2CB447A0CD9890722B56
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/0C6259231C9396B3821624E2F36D090E53F91524E840521C076AA4CCF48FF57731E91135B2BF2CB447A0CD9890722B56
http://www.w3.org/2000/01/rdf-schema#comment
"Data suggest that Retinoic Acid Receptor Responder (RARRES1)/ Tazarotene-induced gene-1 (TIG-1) may serve as a target for therapeutic intervention both in cancer and in angiogenesis-related disorders."
xsd:string
http://purl.uniprot.org/uniprot/#_5651997CB3BA4F3662E657444A6840BBA670981F698F0BC264AA20F7BFEA9F5C237354D685613D346F7F78C1DC794D9E
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/0C6259231C9396B3821624E2F36D090E53F91524E840521C076AA4CCF48FF57731E91135B2BF2CB447A0CD9890722B56
http://purl.uniprot.org/uniprot/P49788
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/0C6259231C9396B3821624E2F36D090E53F91524E840521C076AA4CCF48FF57731E91135B2BF2CB447A0CD9890722B56
http://purl.uniprot.org/uniprot/#_P49788-mappedCitation-28678839
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/0C6259231C9396B3821624E2F36D090E53F91524E840521C076AA4CCF48FF57731E91135B2BF2CB447A0CD9890722B56